NO20040479L - Solvater av lerkanidipinhydroklorid og nye krystallinske former av lerkanidipinhydroklorid. - Google Patents
Solvater av lerkanidipinhydroklorid og nye krystallinske former av lerkanidipinhydroklorid.Info
- Publication number
- NO20040479L NO20040479L NO20040479A NO20040479A NO20040479L NO 20040479 L NO20040479 L NO 20040479L NO 20040479 A NO20040479 A NO 20040479A NO 20040479 A NO20040479 A NO 20040479A NO 20040479 L NO20040479 L NO 20040479L
- Authority
- NO
- Norway
- Prior art keywords
- lercanidipine hydrochloride
- solvates
- crystalline forms
- new crystalline
- lercanidipine
- Prior art date
Links
- WMFYOYKPJLRMJI-UHFFFAOYSA-N Lercanidipine hydrochloride Chemical compound Cl.COC(=O)C1=C(C)NC(C)=C(C(=O)OC(C)(C)CN(C)CCC(C=2C=CC=CC=2)C=2C=CC=CC=2)C1C1=CC=CC([N+]([O-])=O)=C1 WMFYOYKPJLRMJI-UHFFFAOYSA-N 0.000 title 2
- 229960002162 lercanidipine hydrochloride Drugs 0.000 title 2
- 239000012453 solvate Substances 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/80—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
- C07D211/84—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
- C07D211/90—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
- A61P3/14—Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Endocrinology (AREA)
- Rheumatology (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Hydrogenated Pyridines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IT2001MI001727A ITMI20011727A1 (it) | 2001-08-06 | 2001-08-06 | Solvati della lercanidipina cloridrato e nuove forme cristalline della lercanidipina cloridrato ottenute da essi |
| PCT/EP2002/008700 WO2003014085A1 (en) | 2001-08-06 | 2002-08-05 | Solvates of lercanidipine hydrochloride and new crystalline forms of lercanidipine hydrochloride |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NO20040479L true NO20040479L (no) | 2004-02-03 |
Family
ID=11448246
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20040479A NO20040479L (no) | 2001-08-06 | 2004-02-03 | Solvater av lerkanidipinhydroklorid og nye krystallinske former av lerkanidipinhydroklorid. |
Country Status (21)
| Country | Link |
|---|---|
| EP (1) | EP1423367B1 (no) |
| JP (1) | JP2005502648A (no) |
| KR (1) | KR100912664B1 (no) |
| CN (1) | CN100494175C (no) |
| AR (1) | AR037230A1 (no) |
| AT (1) | ATE294162T1 (no) |
| AU (1) | AU2002331390B2 (no) |
| BR (1) | BR0211738A (no) |
| DE (1) | DE60203919D1 (no) |
| EA (1) | EA200400279A1 (no) |
| ES (1) | ES2209684T1 (no) |
| HR (1) | HRP20040157A2 (no) |
| HU (1) | HUP0401161A3 (no) |
| IL (2) | IL153916A0 (no) |
| IT (1) | ITMI20011727A1 (no) |
| MX (1) | MXPA04001073A (no) |
| NO (1) | NO20040479L (no) |
| PE (1) | PE20030350A1 (no) |
| PL (1) | PL369449A1 (no) |
| UY (1) | UY27409A1 (no) |
| WO (1) | WO2003014085A1 (no) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR100651212B1 (ko) | 2004-10-27 | 2006-12-01 | 제일약품주식회사 | 무정형 레르카니디핀의 제조방법 |
| AR052918A1 (es) | 2005-02-25 | 2007-04-11 | Recordati Ireland Ltd | Clorhidrato de lercanidipina amorfo |
| EP1940790B1 (en) * | 2005-09-16 | 2015-09-02 | Glenmark Pharmaceuticals Limited | Polymorphic form of lercanidipine hydrochloride and process for the preparation thereof |
| CN101868442A (zh) * | 2007-03-05 | 2010-10-20 | 阿克塔维什集团Ptc公司 | 盐酸乐卡地平多晶型物和1,1,n-三甲基-n-(3,3-二苯基丙基)-2-氨基乙酰醋酸乙酯的改进制法 |
| WO2008136392A1 (ja) * | 2007-04-27 | 2008-11-13 | Ajinomoto Co., Inc. | 経口投与用製剤 |
| WO2011161223A2 (en) | 2010-06-23 | 2011-12-29 | Krka, Tovarna Zdravil, D.D., Novo Mesto | Pharmaceutical oral dosage forms comprising lercanidipine and enalapril and their pharmaceutically acceptable salts |
| WO2012085249A2 (en) | 2010-12-24 | 2012-06-28 | Krka, D.D., Novo Mesto | Homogenous pharmaceutical oral dosage forms comprising lercanidipine and enalapril or their pharmaceutically acceptable salts |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB8403866D0 (en) * | 1984-02-14 | 1984-03-21 | Recordati Chem Pharm | Diphenylalkylaminoalkyl esters |
| US5912351A (en) * | 1995-05-12 | 1999-06-15 | Recordati, S.A. Chemical And Pharmaceutical Company | Anhydrous 1,4-Dihydropyridines and salts thereof |
-
2001
- 2001-08-06 IT IT2001MI001727A patent/ITMI20011727A1/it unknown
-
2002
- 2002-08-02 AR ARP020102957A patent/AR037230A1/es not_active Application Discontinuation
- 2002-08-05 EA EA200400279A patent/EA200400279A1/ru unknown
- 2002-08-05 MX MXPA04001073A patent/MXPA04001073A/es not_active Application Discontinuation
- 2002-08-05 PL PL02369449A patent/PL369449A1/xx unknown
- 2002-08-05 WO PCT/EP2002/008700 patent/WO2003014085A1/en not_active Ceased
- 2002-08-05 EP EP02767318A patent/EP1423367B1/en not_active Expired - Lifetime
- 2002-08-05 HR HR20040157A patent/HRP20040157A2/hr not_active Application Discontinuation
- 2002-08-05 AT AT02767318T patent/ATE294162T1/de not_active IP Right Cessation
- 2002-08-05 IL IL15391602A patent/IL153916A0/xx unknown
- 2002-08-05 ES ES02767318T patent/ES2209684T1/es active Pending
- 2002-08-05 HU HU0401161A patent/HUP0401161A3/hu unknown
- 2002-08-05 KR KR1020047001791A patent/KR100912664B1/ko not_active Expired - Fee Related
- 2002-08-05 DE DE60203919T patent/DE60203919D1/de not_active Expired - Lifetime
- 2002-08-05 CN CNB028155114A patent/CN100494175C/zh not_active Expired - Fee Related
- 2002-08-05 JP JP2003519035A patent/JP2005502648A/ja active Pending
- 2002-08-05 BR BR0211738-0A patent/BR0211738A/pt not_active IP Right Cessation
- 2002-08-05 AU AU2002331390A patent/AU2002331390B2/en not_active Ceased
- 2002-08-06 PE PE2002000716A patent/PE20030350A1/es not_active Application Discontinuation
- 2002-08-06 UY UY27409A patent/UY27409A1/es not_active Application Discontinuation
-
2003
- 2003-01-13 IL IL153916A patent/IL153916A/en unknown
-
2004
- 2004-02-03 NO NO20040479A patent/NO20040479L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| JP2005502648A (ja) | 2005-01-27 |
| BR0211738A (pt) | 2004-09-28 |
| DE60203919D1 (de) | 2005-06-02 |
| CN1538958A (zh) | 2004-10-20 |
| EP1423367A1 (en) | 2004-06-02 |
| HUP0401161A2 (hu) | 2004-09-28 |
| AU2002331390B2 (en) | 2008-06-05 |
| EP1423367B1 (en) | 2005-04-27 |
| ITMI20011727A1 (it) | 2003-02-06 |
| CN100494175C (zh) | 2009-06-03 |
| AR037230A1 (es) | 2004-11-03 |
| ATE294162T1 (de) | 2005-05-15 |
| UY27409A1 (es) | 2003-03-31 |
| IL153916A (en) | 2008-07-08 |
| IL153916A0 (en) | 2003-07-31 |
| EA200400279A1 (ru) | 2004-06-24 |
| PL369449A1 (en) | 2005-04-18 |
| HUP0401161A3 (en) | 2009-04-28 |
| MXPA04001073A (es) | 2005-02-17 |
| PE20030350A1 (es) | 2003-06-06 |
| KR100912664B1 (ko) | 2009-08-17 |
| HRP20040157A2 (en) | 2004-08-31 |
| WO2003014085A1 (en) | 2003-02-20 |
| ITMI20011727A0 (it) | 2001-08-06 |
| ES2209684T1 (es) | 2004-07-01 |
| KR20040030932A (ko) | 2004-04-09 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO20040072L (no) | Nye substituerte benzimidazol-doseringsformer og fremgangsmate for anvendelse av samme | |
| DK1227088T3 (da) | Krystallinsk base af citalopram og hydrochlorid- eller hydrobromidsaltet deraf | |
| NO20031744D0 (no) | Nye ikke-imadazolforbindelser og farmasöytisk preparat omfattende slike | |
| DK1400518T3 (da) | Heterocycliske forbindelser og lægemidler | |
| NO20034187D0 (no) | Nye spirotricykliske derivater og anvendelse derav som fosfodiesterase-7 inhibitorer | |
| NO20015547D0 (no) | Halvsyntetisk fremgangsmåte og nye forbindelser | |
| NO20023319D0 (no) | Substituerte glutarimider og deres anvendelse som inhibitorer av IL-12-produksjonen | |
| NO20014135D0 (no) | Nye sulfonamidforbindelser og deres anvendelse | |
| NO20005266L (no) | Nye substituerte amider, deres fremstilling og anvendelse | |
| DK1429769T3 (da) | Nye formuleringer og anvendelse deraf | |
| NO20040405L (no) | Farmasoytiske sammensetninger av amlodipin og atorvastatin. | |
| NO20040390L (no) | Krystallinske former VI og VII av atorvastatinkalsium. | |
| NO20021786L (no) | Skumdempningsfremgangsmåter og sammensetninger | |
| DK1432683T3 (da) | Hidtil ukendte krystallinske polymorfe former af lercanidipinhydrochlorid og fremgangsmåder til fremstilling heraf | |
| NO20033854D0 (no) | N-but-3-enyl-norbuprenorfin og fremgangsmåter for anvendelse | |
| NO20041187L (no) | Metoder og blandinger av nye triazinforbindelser | |
| DE60232955D1 (de) | Kammförmiges, piezoelektrisches stellglied und herstellungsverfahren dafür | |
| DK1578738T3 (da) | Escitalopram-hydrobromid og fremgangsmåde til fremstilling deraf | |
| NO20040479L (no) | Solvater av lerkanidipinhydroklorid og nye krystallinske former av lerkanidipinhydroklorid. | |
| IS7289A (is) | Kristallaður venlafaxínbasi og nýir fjölgervingarvenlafaxínhýdróklóríðs, aðferðir til að framleiðaþá | |
| NO20035332D0 (no) | Nye heterocykliske derivater og medisinsk anvendelse derav | |
| NO20031928L (no) | Nye krystall- og solvatformer av ondansetron-hydroklorid og fremgangmsmåterfor fremstilling derav | |
| NO20030822D0 (no) | Nye forbindelser og fremgangsmåter | |
| NO20035331D0 (no) | Nye heterocyklisk forbindelse og medisinsk anvendelse derav | |
| DK1429770T3 (da) | Nye formuleringer og anvendelse deraf |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |